Trademark: 97248087
Word
ENANTA PHARMACEUTICALS
Status Date
Tuesday, August 6, 2024
Filing Date
Tuesday, February 1, 2022
Published for Opposition
Tuesday, December 27, 2022
5 Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disorders
Feb 4, 2022
New Application Entered
Feb 7, 2022
New Application Office Supplied Data Entered
Nov 14, 2022
Assigned To Examiner
Nov 18, 2022
Examiners Amendment -Written
Nov 18, 2022
Examiners Amendment E-Mailed
Nov 18, 2022
Notification Of Examiners Amendment E-Mailed
Nov 18, 2022
Examiner's Amendment Entered
Nov 18, 2022
Approved For Pub - Principal Register
Dec 7, 2022
Notification Of Notice Of Publication E-Mailed
Dec 27, 2022
Published For Opposition
Dec 27, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2023
Sou Teas Extension Received
Aug 16, 2023
Sou Extension 1 Filed
Aug 16, 2023
Sou Extension 1 Granted
Feb 13, 2024
Sou Extension 2 Granted
Aug 6, 2024
Sou Teas Extension Received
Aug 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 6, 2024
Sou Extension 3 Filed
Aug 6, 2024
Sou Extension 3 Granted
Feb 13, 2024
Sou Extension 2 Filed
Feb 13, 2024
Sou Teas Extension Received
Feb 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2024
Teas Statement Of Use Received
Trademark Alertz updated from USPTO on 2030-01-24
